Role of cytokine levels in assessment of prognosis and post-treatment outcome in hepatocellular carcinoma

[1]  Chung-Pin Li,et al.  Cytokines are associated with postembolization fever and survival in hepatocellular carcinoma patients receiving transcatheter arterial chemoembolization , 2013, Hepatology International.

[2]  Ying Wang,et al.  Elevated Pretherapy Serum IL17 in Primary Hepatocellular Carcinoma Patients Correlate to Increased Risk of Early Recurrence after Curative Hepatectomy , 2012, PloS one.

[3]  J. Jang,et al.  Serum interleukin-6 and C-reactive protein as a prognostic indicator in hepatocellular carcinoma. , 2012, Cytokine.

[4]  F. Farinati,et al.  Transcatheter Arterial Chemoembolization (TACE) in Hepatocellular Carcinoma (HCC): The Role of Angiogenesis and Invasiveness , 2008, The American Journal of Gastroenterology.

[5]  Shou-Dong Lee,et al.  Fever after transcatheter arterial chemoembolization for hepatocellular carcinoma: incidence and risk factor analysis , 2008, Scandinavian journal of gastroenterology.

[6]  X. Wang,et al.  The role of cytokines in hepatocellular carcinoma , 2006, Journal of leukocyte biology.

[7]  M. Zoli,et al.  Diagnostic and Prognostic Role of α-Fetoprotein in Hepatocellular Carcinoma: Both or Neither? , 2006, The American Journal of Gastroenterology.

[8]  M. Matsuda,et al.  Role of interleukin‐18 and its receptor in hepatocellular carcinoma associated with hepatitis C virus infection , 2006, International journal of cancer.

[9]  A. Zekri,et al.  Cytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progression. , 2005, World journal of gastroenterology.

[10]  J. Dufour,et al.  Angiogenesis and hepatocellular carcinoma. , 2004, Journal of hepatology.

[11]  J. Dufour,et al.  Effect of vascular endothelial growth factor on functional recovery after hepatectomy in lean and obese mice. , 2004, Journal of hepatology.

[12]  P. Majno,et al.  Acute portal hemodynamics and cytokine changesfollowing selective transarterial chemoembolization in patients with cirrhosis and hepatocellular carcinoma. , 2003, Medical science monitor : international medical journal of experimental and clinical research.

[13]  H. Kawasaki,et al.  Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C. , 2003, Hepato-gastroenterology.

[14]  H. Ithnin,et al.  Expression of interleukin-18, interferon-γ and interleukin-10 in hepatocellular carcinoma , 2002 .

[15]  L. Giacomelli,et al.  Cytokine, infiltrating macrophage and T cell-mediated response to development of primary and secondary human liver cancer. , 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[16]  N. Tanaka,et al.  Analysis of Host Response to Hepatectomy by Simultaneous Measurement of Cytokines in the Portal Vein, Caval Vein and Radial Artery , 2002, The Journal of international medical research.

[17]  H. Ithnin,et al.  Expression of interleukin-18, interferon-gamma and interleukin-10 in hepatocellular carcinoma. , 2002, Immunology Letters.

[18]  C. Chi,et al.  Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma. , 2000, Annals of surgery.

[19]  T. Okanoue,et al.  Hepatic damage induced by transcatheter arterial chemoembolization elevates serum concentrations of macrophage-colony stimulating factor. , 1999, Liver.

[20]  H. Miyake,et al.  Clinical Relevance of Antibiotic-induced Endotoxin Release in Patients Undergoing Hepatic Resection RID="" ID="" This International Society of Surgery (ISS)/Société Internationale de Chirurgie (SIC) article was presented at the 37th World Congress of Surgery International Surgical Week (ISW97), Acap , 1999, World Journal of Surgery.

[21]  伊藤 善基.  Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma , 1998 .

[22]  T. Ishikawa,et al.  Serum levels of IL‐10, IL‐15 and soluble tumour necrosis factor‐alpha (TNF‐α) receptors in type C chronic liver disease , 1997, Clinical and experimental immunology.

[23]  H. Nakazaki.  Preoperative and postoperative cytokines in patients with cancer , 1992, Cancer.

[24]  T. Kishimoto,et al.  The biology of interleukin-6. , 1989, Blood.